Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.
Barsam SJ. et al, (2011), Blood, 117, 5723 - 5732
Absolute bioavailability of PF-01367338 tablets following oral administration in cancer patients.
Wang DD. et al, (2011), JOURNAL OF CLINICAL ONCOLOGY, 29
Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater
Neoptolemos JP. et al, (2011), JOURNAL OF CLINICAL ONCOLOGY, 29
Phase I (Ph) safety, pharmacodynamic (PD), and pharmacokinetic (PK) trial of a pure MEK inhibitor (i), RO4987655, in patients with advanced /metastatic solid tumor.
Leijen S. et al, (2011), JOURNAL OF CLINICAL ONCOLOGY, 29
Phase I study of OSI-906, dual tyrosine kinase inhibitor of insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR) in combination with erlotinib (E) in patients with advanced solid tumors.
Macaulay VM. et al, (2011), JOURNAL OF CLINICAL ONCOLOGY, 29
Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies.
Olmos D. et al, (2011), Clin Cancer Res, 17, 3420 - 3430
Does metabolic response at repeat PET/CT examination predict pathological response to neoadjuvant chemotherapy in oesophageal cancer?
Gillies RS. et al, (2011), BRITISH JOURNAL OF SURGERY, 98, 7 - 7
METFORMIN'S EFFECTS ON BREAST CANCER LIPID METABOLISM
Lord SR. et al, (2011), ANNALS OF ONCOLOGY, 22, 31 - 31
METFORMIN'S EFFECTS ON BREAST CANCER LIPID METABOLISM
Lord SR. et al, (2011), ANNALS OF ONCOLOGY, 22
Polo-like kinase Plk2 is an epigenetic determinant of chemosensitivity and clinical outcomes in ovarian cancer.
Syed N. et al, (2011), Cancer Res, 71, 3317 - 3327
The biological and therapeutic relevance of mRNA translation in cancer.
Blagden SP. and Willis AE., (2011), Nat Rev Clin Oncol, 8, 280 - 291
Tumour expression of the DNA repair protein, XPF, predicts pathological response to neoadjuvant oxaliplatin chemotherapy in oesophageal cancer
Gillies RS. et al, (2011), BRITISH JOURNAL OF SURGERY, 98, 3 - 3
Shared care protocol for the management of essential thrombocythaemia patients in primary care
Sweeney C. et al, (2011), BRITISH JOURNAL OF HAEMATOLOGY, 153, 55 - 55
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours.
Khan OA. et al, (2011), Br J Cancer, 104, 750 - 755
Circulating melanoma cells and survival in metastatic melanoma.
Rao C. et al, (2011), Int J Oncol, 38, 755 - 760
Additional benefit of ¹⁸F-fluorodeoxyglucose integrated positron emission tomography/computed tomography in the staging of oesophageal cancer.
Gillies RS. et al, (2011), Eur Radiol, 21, 274 - 280
Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia.
Goardon N. et al, (2011), Cancer Cell, 19, 138 - 152